myelopeptide 1 has been researched along with Lupus Erythematosus, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komponiec, NA; Mikhailova, AA; Sorokin, SV | 1 |
| Apostoloff, E; Grunow, R; Hiepe, F; Jahn, S; Kiessig, ST; Volk, HD; Von Baehr, R | 1 |
2 other study(ies) available for myelopeptide 1 and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Myelopeptides effect on longevity and immunological parameters in mice with congenital immunodeficiency.
Topics: Adjuvants, Immunologic; Anemia, Macrocytic; Animals; Autoimmune Diseases; Bone Marrow; Bone Marrow Cells; Hematopoiesis; Immunologic Deficiency Syndromes; Immunologic Factors; Longevity; Lupus Erythematosus, Systemic; Mice; Mice, Mutant Strains; Oligopeptides; Peptides; Swine | 1991 |
A myelopeptide from unstimulated bone marrow cells with immunomodulatory activity in lymphocyte cultures from healthy donors and patients with hypogammaglobulinemia and active lupus erythematosus.
Topics: Agammaglobulinemia; Bone Marrow; Cells, Cultured; Female; HLA-D Antigens; Humans; Immunoglobulin G; Immunoglobulin M; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocytes; Male; Oligopeptides; Peptide Biosynthesis; Peptides | 1988 |